Adam Taich - 23 Oct 2024 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Financial Officer
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Adam Taich
Issuer symbol
TXG
Transactions as of
23 Oct 2024
Net transactions value
$0
Form type
4
Filing time
19 Mar 2025, 17:34:38 UTC
Previous filing
20 Aug 2024
Next filing
27 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Award $0 +201,704 $0.000000 201,704 23 Oct 2024 Direct F1
transaction TXG Class A Common Stock Award $0 +133,928 +66% $0.000000 335,632 17 Mar 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on August 21, 2024 and 1/16th of the RSUs shall vest on each quarterly anniversary thereafter for the following three years, subject to the Reporting Person continuing as a service provider through each such date.
F2 Constitute RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2025, subject to the Reporting Person continuing as a service provider through each such date.